510(k) Report

510(k) · Cleared

Cleared

LOSPA TKR System Instrumentation, EXULT TKR System Instrumentation

K222278510(k) SpecialCleared Aug 26, 202228-day reviewClass II21 CFR 888.3560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Corentec Co., Ltd. · JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer

Cleared on Aug 26, 2022 as substantially equivalent to K160157 (Corentec Co., Ltd., 2016) and 2 other predicates after a 28-day review. Its family tree reaches back 8 generations to 1987.

Decided
Aug 26, 2022
Review
28 days
Class
Class II
Product code
JWH
Recalls
None
Predicates
3

Its longest line of descent runs back 8 generations to K870730 (1987). 37 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 8 generations backK870730 Noiles Total Knee ProsthesisJoint Medical Products Corp. · 1987
  2. 7 generations backK003182 Orthogenesis LPS SystemDepuy, Inc. · 2001
  3. 6 generations backK040281 LPS Metaphyseal Sleeve (Limb Preservation System)DePuy Orthopaedics, Inc. · 2004
  4. 5 generations backK060515 Depuy PFC Sigma Knee ProsthesisDePuy Orthopaedics, Inc. · 2006
  5. 4 generations backK110404 Eaum Total Knee SystemCorentec Co., Ltd. · 2012 · Recalled
  6. 3 generations backK121037 Lospa Tibial Base PlateCorentec Co., Ltd. · 2012
  7. 2 generations backK130673 Lospa Total Knee Replacement SystemCorentec Co., Ltd. · 2013 · Recalled
  8. 1 generation backK192507 LOSPA II Knee SystemCorentec Co., Ltd. · 2019
  9. This deviceK222278 LOSPA TKR System Instrumentation, EXULT TKR System InstrumentationCorentec Co., Ltd. · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K870730Noiles Total Knee ProsthesisJoint Medical Products Corp.1987—
−7K003182Orthogenesis LPS SystemDepuy, Inc.2001—
−6K040281LPS Metaphyseal Sleeve (Limb Preservation System)DePuy Orthopaedics, Inc.2004—
−5K060515Depuy PFC Sigma Knee ProsthesisDePuy Orthopaedics, Inc.2006—
−4K110404Eaum Total Knee SystemCorentec Co., Ltd.20122
−3K121037Lospa Tibial Base PlateCorentec Co., Ltd.2012—
−2K130673Lospa Total Knee Replacement SystemCorentec Co., Ltd.20132
−1K192507LOSPA II Knee SystemCorentec Co., Ltd.2019—
0 (this device)K222278LOSPA TKR System Instrumentation, EXULT TKR System InstrumentationCorentec Co., Ltd.2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199110
199230
199320
199420
199520
199640
199730
199820
200010
200320
200420
200610
200810
201010
201610
FIG. 1 — Lineage of K222278, 1987–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JWH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JWH device

  1. #1 K221479 Persona Personalized Knee Systemscore 22.4 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160157LOSPA Modular Knee System
Summary page 5
…egally Marketed Device(s) to Which Equivalence is Claimed 510(k) Number Trade Name Submitter Product Code Primary K160157 LOSPA Modular Knee System JWH, MBH K192507 LOSPA II Knee System…
Corentec Co., Ltd.20162
*K192507LOSPA II Knee System
Summary page 5
…Name Submitter Product Code Primary K160157 LOSPA Modular Knee System JWH, MBH K192507 LOSPA II Knee System JWH LOSPA Total Knee System…
Corentec Co., Ltd.2019—
*K110404Eaum Total Knee System
Summary page 5
…WH, MBH K192507 LOSPA II Knee System JWH LOSPA Total Knee System K110404 JWH (EAUM Total Knee System)…
Corentec Co., Ltd.20122
†K130673Lospa Total Knee Replacement SystemCorentec Co., Ltd.20132
†K200395LOSPA II Knee System (EXULT Knee Replacement System)Corentec Co., Ltd.2020—
†K201851EXULT Femoral component trial - Left, EXULT Femoral component trial - RightCorentec Co., Ltd.2020—
†K212034LOSPA TKR SystemCorentec Co., Ltd.2021—

Also cleared against K160157: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 35 years and passes through 4 companies; a new generation was cleared every 3.0 years on median.
  • 17 of the 37 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K160157.

How does its category compare?

All JWH devices

JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · JWH

20in 2025

2007: 182008: 172009: 112010: 192011: 252012: 332013: 312014: 332015: 272016: 182017: 252018: 252019: 282020: 222021: 242022: 172023: 202024: 192025: 202026 (partial year): 12
2007high 33 (2012) · low 11 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JWH

55in 2025

2007: 74 days median2008: 81 days median2009: 168 days median2010: 85 days median2011: 87 days median2012: 85 days median2013: 128 days median2014: 98 days median2015: 87 days median2016: 88 days median2017: 118 days median2018: 90 days median2019: 133 days median2020: 59 days median2021: 61 days median2022: 56 days median2023: 57 days median2024: 89 days median2025: 55 days median2026 (partial year): 63 days median
2007high 168 (2009) · low 55 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JWH

2in 2025

2007: 142008: 102009: 1092010: 322011: 272012: 852013: 312014: 132015: 112016: 172017: 612018: 142019: 52020: 22021: 82022: 122023: 672024: 72025: 22026 (partial year): 4
2007high 109 (2009) · low 2 (2020)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JWH

9,306in 2025

2007: 1,3052008: 1,4832009: 1,8702010: 3,2862011: 5,1332012: 5,2032013: 6,1352014: 6,7222015: 6,8812016: 7,5862017: 12,2632018: 14,0712019: 14,9872020: 12,5922021: 9,4082022: 8,3642023: 8,9472024: 10,8282025: 9,306
2007high 14,987 (2019) · low 1,305 (2007)2025

MAUDE reports naming product code JWH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071874141,305
20081781101,483
2009111681091,870
20101985323,286
20112587275,133
20123385855,203
201331128316,135
20143398136,722
20152787116,881
20161888177,586
2017251186112,263
201825901414,071
201928133514,987
20202259212,592
2021246189,408
20221756128,364
20232057678,947
20241989710,828
2025205529,306
202612634—

What is it indicated for?

LOSPA TKR System is intended for use in total knee arthroplasty surgery for the following indications: • Painful, disabling joint disease of the knee resulting from non-inflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis or avascular necrosis) or rheumatoid arthritis; • Post-traumatic loss of knee joint configuration and function; • Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be…

Read the full statement (180 words)

LOSPA TKR System is intended for use in total knee arthroplasty surgery for the following indications:

• Painful, disabling joint disease of the knee resulting from non-inflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis or avascular necrosis) or rheumatoid arthritis;

• Post-traumatic loss of knee joint configuration and function;

• Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability;

• Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous arthroplasty procedure.

LOSPA TKR System is intended for cemented application only.

EXULT Knee System is intended for the treatment of diseases as follows:

• Painful, disabling joint disease of the knee resulting from non-inflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis or avascular necrosis) or rheumatoid arthritis;

• Post-traumatic loss of knee joint configuration and function;

• Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability;

• Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous arthroplasty procedure.

EXULT Knee System is intended for cemented application only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K222278: LOSPA TKR System Instrumentation, EXULT TKR System Instrumentation.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K222278

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026